However, third-generation FAP-targeting CAR-T cells in this study showed limited antitumor activity and induction of cachexia and other toxicities, which were attributed to the expression of FAP on bone marrow stromal cells that could also be recognized in an on-target/off-tumor fashion [77]. The gene discussed is FAP; the disease is Cachexia.